Re: RVX Market Value
|
4
|
Resverlogix Corp.
|
Jan 28, 2021 07:11PM
|
Re: Article
|
4
|
Resverlogix Corp.
|
May 30, 2022 12:45PM
|
Re: New Pfizer Antiviral Drug
|
4
|
Resverlogix Corp.
|
Nov 05, 2021 08:08PM
|
Re: great,good,bad,ugly or so so??
|
4
|
Resverlogix Corp.
|
May 19, 2022 02:08AM
|
Re: Resverlogix Reschedules Update Webcast and Conference Call: Now February 4th 10AM MT
|
4
|
Resverlogix Corp.
|
Jan 27, 2021 06:20PM
|
Good luck!
|
4
|
Resverlogix Corp.
|
Sep 18, 2021 05:53PM
|
Re: Seems to be some interest
|
4
|
Resverlogix Corp.
|
Apr 12, 2022 01:19PM
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
4
|
Resverlogix Corp.
|
Apr 12, 2021 07:21PM
|
Re: Nonprofit Think Tank
|
3
|
Zenith Epigenetics
|
Oct 05, 2020 10:20PM
|
Re: Our own BKC on the webcast
|
3
|
Resverlogix Corp.
|
Feb 06, 2021 11:05AM
|
Re: Round one
|
3
|
Resverlogix Corp.
|
Jan 27, 2022 01:05AM
|
WHO reports that 40% to 75% of Nipah cases are fatal compared to COVID-19 fatality rate of around 2%.
|
3
|
Resverlogix Corp.
|
Sep 09, 2021 02:26PM
|
Re: RVX 208 and the cytokine storm syndrome
|
3
|
Resverlogix Corp.
|
Apr 20, 2020 12:20PM
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
3
|
Resverlogix Corp.
|
Dec 13, 2021 08:59AM
|
Re: IR response
|
3
|
Resverlogix Corp.
|
Jan 11, 2022 03:03PM
|
Whatever happened to the update on our trial? Stalled like everything else here.
|
3
|
Resverlogix Corp.
|
Apr 23, 2020 05:24PM
|
Re: Interesting.
|
3
|
Resverlogix Corp.
|
Nov 23, 2021 12:56AM
|
Re: Our own BKC on the webcast
|
3
|
Resverlogix Corp.
|
Feb 06, 2021 04:51PM
|
New name.
|
3
|
Resverlogix Corp.
|
May 10, 2022 07:11PM
|
Re: Shawn lu RSU and option cancelled
|
3
|
Resverlogix Corp.
|
Apr 06, 2020 02:27PM
|